Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
31-32
|
| pubmed:dateCreated |
1980-12-18
|
| pubmed:language |
ger
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
0025-8512
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
8
|
| pubmed:volume |
31
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1135-7
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:7421547-Adult,
pubmed-meshheading:7421547-Aldosterone,
pubmed-meshheading:7421547-Blood Pressure,
pubmed-meshheading:7421547-Female,
pubmed-meshheading:7421547-Humans,
pubmed-meshheading:7421547-Hypertension,
pubmed-meshheading:7421547-Male,
pubmed-meshheading:7421547-Middle Aged,
pubmed-meshheading:7421547-Spironolactone
|
| pubmed:year |
1980
|
| pubmed:articleTitle |
[Hypotensive effect of spironolactone in patients with essential hypertension and aldosterone regulation disorders].
|
| pubmed:publicationType |
Journal Article
|